Biocompatibility of a coacervate-based controlled release system for protein delivery to the injured spinal cord
Source abstract
Abstract
The efficacy of protein-based therapies for treating injured nervous tissue is limited by the short half-life of free proteins in the body. Affinity-based biomaterial delivery systems provide sustained release of proteins, thereby extending the efficacy of such therapies. Here, we investigated the biocompatibility of a novel coacervate delivery system based on poly(ethylene argininylaspartate diglyceride) (PEAD) and heparin in the damaged spinal cord. We found that the presence of the [PEAD:heparin] coacervate did not affect the macrophage response, glial scarring or nervous tissue loss, which are hallmarks of spinal cord injury. Moreover, the density of axons, including serotonergic axons, at the injury site and the recovery of motor and sensorimotor function were comparable in rats with and without the coacervate. These results revealed the biocompatibility of our delivery system and supported its potential to deliver therapeutic proteins to the injured nervous system.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Nerve injury and regeneration · RNA Interference and Gene Delivery · Electrospun Nanofibers in Biomedical Applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (43)
Show source-provided references
1. Materials for central nervous system regeneration: bioactive cues10.1039/c0jm04335d ↗
2. Neurotrophic factors in central nervous system trauma10.1089/neu.1995.12.853 ↗
3. Neurotrophins reduce degeneration of injured ascending sensory and corticospinal motor axons in adult rat spinal cord10.1006/exnr.2002.7901 ↗
4. Neurotrophin-3 and brain-derived neurotrophic factor induce oligodendrocyte proliferation and myelination of regenerating axons in the contused adult rat spinal cord10.1523/JNEUROSCI.18-14-05354.1998 ↗
5. Neurotrophins BDNF and NT-3 promote axonal re-entry into the distal host spinal cord through Schwann cell-seeded mini-channels
6. Neurotrophic factors increase axonal growth after spinal cord injury and transplantation in the adult rat10.1006/exnr.1997.6705 ↗
7. Motoneuron BDNF/TrkB signaling enhances functional recovery after cervical spinal cord injury10.1016/j.expneurol.2013.04.002 ↗
8. A combination of BDNF and NT-3 promotes supraspinal axonal regeneration into Schwann cell grafts in adult rat thoracic spinal cord10.1006/exnr.1995.1056 ↗
9. Intrathecal epidermal growth factor and fibroblast growth factor-2 exacerbate meningeal proliferative lesions associated with intrathecal catheters10.1227/01.NEU.0000255441.59612.98 ↗
10. Design, synthesis, and biocompatibility of an arginine-based polyester10.1002/btpr.728 ↗
11. A [polycation:heparin] complex releases growth factors with enhanced bioactivity10.1016/j.jconrel.2010.11.025 ↗
12. Control growth factor release using a self-assembled [polycation:heparin] complex10.1371/journal.pone.0011017 ↗
13. Controlled delivery of heparin-binding EGF-like growth factor yields fast and comprehensive wound healing10.1016/j.jconrel.2012.11.004 ↗
14. Controlled delivery of sonic hedgehog morphogen and its potential for cardiac repair10.1371/journal.pone.0063075 ↗
15. Sustained release of bone morphogenetic protein 2 via coacervate improves the osteogenic potential of muscle-derived stem cells10.5966/sctm.2013-0027 ↗
16. Injectable fibroblast growth factor-2 coacervate for persistent angiogenesis10.1073/pnas.1110121108 ↗
17. Sonic hedgehog in CNS development: one signal, multiple outputs10.1016/S0166-2236(02)02062-3 ↗
18. A sensitive and reliable locomotor rating scale for open field testing in rats10.1089/neu.1995.12.1 ↗
19. Degenerative and spontaneous regenerative processes after spinal cord injury10.1089/neu.2006.23.263 ↗
20. Cellular and molecular mechanisms of glial scarring and progressive cavitation: in vivo and in vitroanalysis of inflammation-induced secondary injury after CNS trauma10.1523/JNEUROSCI.19-19-08182.1999 ↗
21. The macrophage in acute neural injury: changes in cell numbers over time and levels of cytokine production in mammalian central and peripheral nervous systems10.1242/jeb.203.12.1783 ↗
22. System xc − regulates microglia and macrophage glutamate excitotoxicity in vivo10.1016/j.expneurol.2011.10.025 ↗
23. Identification of two distinct macrophage subsets with divergent effects causing either neurotoxicity or regeneration in the injured mouse spinal cord10.1523/JNEUROSCI.3257-09.2009 ↗
24. Post-traumatic inflammation following spinal cord injury10.1038/sj.sc.3101483 ↗
25. The glial scar and central nervous system repair10.1016/S0361-9230(99)00072-6 ↗
26. CNS injury, glial scars, and inflammation: inhibitory extracellular matrices and regeneration failure10.1016/j.expneurol.2007.05.014 ↗
27. 5-Hydroxytryptamine-induced locomotor rhythm in the neonatal mouse spinal cord in vitro10.1016/S0304-3940(00)00805-3 ↗
28. Activation of the central pattern generators for locomotion by serotonin and excitatory amino acids in neonatal rat10.1113/jphysiol.1992.sp019296 ↗
29. Serotonergic innervation of the caudal spinal stump in rats after complete spinal transection: effect of olfactory ensheathing glia10.1002/cne.22080 ↗
30. Bone marrow stromal cell-mediated tissue sparing enhances functional repair after spinal cord contusion in adult rats10.3727/096368912X640484 ↗
31. The effect of a polyurethane-based reverse thermal gel on bone marrow stromal cell transplant survival and spinal cord repair10.1016/j.biomaterials.2013.11.062 ↗
32. Basic fibroblast growth factor (bFGF) enhances tissue sparing and functional recovery following moderate spinal cord injury10.1089/neu.1999.16.817 ↗
33. Neuroanatomical substrates of functional recovery after experimental spinal cord injury: implications of basic science research for human spinal cord injury10.1093/ptj/80.8.808 ↗
34. The Hedgehog pathway promotes blood–brain barrier integrity and CNS immune quiescence10.1126/science.1206936 ↗
35. Sonic hedgehog regulates angiogenesis and myogenesis during post-natal skeletal muscle regeneration10.1111/j.1582-4934.2008.00440.x ↗
36. Sonic hedgehog regulates adult neural progenitor proliferation in vitro and in vivo10.1038/nn983 ↗
37. Neuroprotective effect of sonic hedgehog up-regulated in Schwann cells following sciatic nerve injury10.1111/j.1471-4159.2008.05666.x ↗
38. Improvement of neurological recovery and stimulation of neural progenitor cell proliferation by intrathecal administration of Sonic hedgehog10.3171/2012.1.JNS111285 ↗
39. Sonic hedgehog-induced neural precursor proliferation after adult rodent spinal cord injury
40. Endogenous stem cell proliferation induced by intravenous hedgehog agonist administration after contusion in the adult rat spinal cord10.3171/2008.10.SPI08231 ↗
41. The effect of long-term release of Shh from implanted biodegradable microspheres on recovery from spinal cord injury in mice10.1016/j.biomaterials.2011.12.048 ↗
42. Reactive glia in the injured brain acquire stem cell properties in response to sonic hedgehog. [Corrected]10.1016/j.stem.2013.01.019 ↗
43. The effect of a heparin-based coacervate of fibroblast growth factor-2 on scarring in the infarcted myocardium10.1016/j.biomaterials.2012.11.019 ↗